-+ 0.00%
-+ 0.00%
-+ 0.00%

AEON Biopharma Q3 EPS $(0.39) Beats $(0.43) Estimate

Benzinga·11/14/2025 13:40:19
Listen to the news
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 96.61 percent increase over losses of $(11.52) per share from the same period last year.